Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
3,376
Views
4
CrossRef citations to date
0
Altmetric
Infectious Diseases

Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal

Fabián P. Alvareza Sanofi, Lyon, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3085-6275
ORCID Icon,
Pierre Chevalierb IQVIA, Zaventem, Belgium
,
Matthias Bormsb IQVIA, Zaventem, Belgium
,
Hélène Bricouta Sanofi, Lyon, FranceORCID Iconhttps://orcid.org/0000-0002-5439-8064
ORCID Icon,
Catia Marquesc Sanofi, Porto Salvo, Portugal
,
Anu Soininend Sanofi, Espoo, Finland
,
Tatu Sainioe Medaffcon Oy, Espoo, Finland
,
Christine Petitf Sanofi, Diegem, Belgium
&
Caroline de Courvillea Sanofi, Lyon, FranceORCID Iconhttps://orcid.org/0000-0001-9396-6071
ORCID Icon show all
Pages 710-719 | Received 03 Feb 2023, Accepted 20 Mar 2023, Published online: 23 May 2023

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sophie Marbaix, Nicolas Dauby & Joaquin Mould-Quevedo. (2023) Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population. Expert Review of Vaccines 22:1, pages 608-619.
Read now
Sanjay Hadigal, Laura Colombo & Joseph Cook. (2023) Reply letter to “Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal”. Journal of Medical Economics 26:1, pages 933-934.
Read now
F.P Alvarez, H. Bricout, C. Marques, A. Soininen, T. Sainio, C. Petit, C. de Courville & P. Chevalierf. (2023) Reply to letter by Hadigal et al. regarding the cost-effectiveness of high dose quadrivalent vaccine in three European countries . Journal of Medical Economics 26:1, pages 1167-1168.
Read now

Articles from other publishers (1)

Maarten Postma, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña & Joaquin Mould-Quevedo. (2023) Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11:6, pages 1089.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.